Company Description
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
The company’s Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry.
Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network.
The company’s products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories.
It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release.
In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions’ Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system.
Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services.
The company was founded in 1999 and is based in Brentwood, Tennessee.
| Country | United States |
| Founded | 1999 |
| Industry | Integrated Freight & Logistics |
| Sector | Industrials |
| Employees | 1,105 |
| CEO | Jerrell Shelton |
Contact Details
Address: 112 Westwood Place, Suite 350 Brentwood, Tennessee 37027 United States | |
| Phone | 949 470 2300 |
| Website | cryoportinc.com |
Stock Details
| Ticker Symbol | CYRX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001124524 |
| CUSIP Number | 229050307 |
| ISIN Number | US2290503075 |
| Employer ID | 88-0313393 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jerrell W. Shelton | Chairman, President and Chief Executive Officer |
| Robert S. Stefanovich MS | Senior Vice President, Chief Financial Officer, Treasurer and Chief Administrative Officer |
| Edward J. Zecchini | Senior Vice President and Chief Digital and Technology Officer |
| Dr. Mark W. Sawicki Ph.D. | Senior Vice President and Chief Scientific Officer |
| Thomas J. Heinzen | Vice President of Corporate Development and Investor Relations |
| Tony Ippolito | Vice President, General Counsel and Corporate Secretary |
| Kylie A. Crowe | Vice President of Global Human Resources and Organizational Development |
| Phil Wilson | Chief Operating Officer of Cryoport Systems, LLC |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| May 8, 2025 | 10-Q | Quarterly Report |
| May 7, 2025 | 8-K | Current Report |
| Apr 25, 2025 | ARS | Filing |
| Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 31, 2025 | 8-K | Current Report |
| Mar 7, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 7, 2025 | 10-K | Annual Report |